Literature DB >> 23902161

A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.

M McCarron1, P McCallion, E Reilly, N Mulryan.   

Abstract

BACKGROUND: To examine dementia characteristics, age at onset and associated comorbidities in persons with Down syndrome.
METHOD: Seventy-seven people with Down syndrome aged 35 years and older were followed longitudinally. The diagnosis of dementia was established using the modified International Classification of Diseases, Tenth Revision (ICD-10) criteria and a combination of objective and informant-based tests. Cognitive tests included the Test for Severe Impairment and the Down Syndrome Mental Status Examination; adaptive behaviour was measured using the Daily Living Skills Questionnaire. The Dementia Questionnaire for Mental Retarded Persons (DMR) was added to the test battery in 2005 and this study includes follow-up data for this instrument.
RESULTS: Over the 14-year period the average age of diagnosis at 55.41 years (SD = 7.14) was in the higher range of previously reported estimates (51-56 years) and a median survival of 7 years after diagnosis. Persons with dementia in the sample were significantly older than persons without dementia. The presence of dementia was also associated with epilepsy and sensory impairments. Among instruments the DMR appeared most sensitive to tracking change in symptoms over time before diagnosis.
CONCLUSION: The previously reported high risk levels for dementia among people with Down syndrome was confirmed in these data as was the value of the instruments utilised in tracking decline and helping to confirm diagnosis even in persons with severe intellectual disability.
© 2013 MENCAP and International Association of the Scientific Study of Intellectual and Developmental Disabilities and John Wiley & Sons Ltd.

Entities:  

Keywords:  Down syndrome; behavioural measurement methods; intellectual disability; learning disability

Mesh:

Year:  2013        PMID: 23902161     DOI: 10.1111/jir.12074

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  60 in total

1.  Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.

Authors:  Sigan L Hartley; Benjamin L Handen; Darlynne Devenny; Iulia Mihaila; Regina Hardison; Patrick J Lao; William E Klunk; Peter Bulova; Sterling C Johnson; Bradley T Christian
Journal:  Neurobiol Aging       Date:  2017-06-02       Impact factor: 4.673

2.  The AT(N) framework for Alzheimer's disease in adults with Down syndrome.

Authors:  Michael S Rafii; Beau M Ances; Nicole Schupf; Sharon J Krinsky-McHale; Mark Mapstone; Wayne Silverman; Ira Lott; William Klunk; Elizabeth Head; Brad Christian; Florence Lai; H Diana Rosas; Shahid Zaman; Melissa E Petersen; Andre Strydom; Juan Fortea; Benjamin Handen; Sid O'Bryant
Journal:  Alzheimers Dement (Amst)       Date:  2020-10-27

3.  Clinicopathological Staging of Dynamics of Neurodegeneration and Neuronal Loss in Alzheimer Disease.

Authors:  Jerzy Wegiel; Michael Flory; Izabela Kuchna; Krzysztof Nowicki; Shuang Yong Ma; Jarek Wegiel; Eulalia Badmaev; Mony de Leon; Thomas Wisniewski; Barry Reisberg
Journal:  J Neuropathol Exp Neurol       Date:  2021-01-01       Impact factor: 3.685

4.  Leisure Activity, Brain β-amyloid, and Episodic Memory in Adults with Down Syndrome.

Authors:  Iulia Mihaila; Benjamin L Handen; Bradley T Christian; Patrick J Lao; Karly A Cody; William E Klunk; Dana L Tudorascu; Annie D Cohen; Ozioma C Okonkwo; Sigan L Hartley
Journal:  Dev Neurobiol       Date:  2019-04-01       Impact factor: 3.964

5.  Identifying dementia in Down syndrome with the Severe Impairment Battery, Brief Praxis Test and Dementia Scale for People with Learning Disabilities.

Authors:  E R Wallace; J P Harp; K L Van Pelt; L M Koehl; A M Caban-Holt; A J Anderson-Mooney; G A Jicha; D D Lightner; W C Robertson; E Head; F A Schmitt
Journal:  J Intellect Disabil Res       Date:  2021-11-16

6.  Prevalence of Aging, Dementia, and Multimorbidity in Older Adults With Down Syndrome.

Authors:  Eleonore Bayen; Katherine L Possin; Yingjia Chen; Laurent Cleret de Langavant; Kristine Yaffe
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 7.  Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.

Authors:  Panagiotis Zis; Andre Strydom
Journal:  Free Radic Biol Med       Date:  2017-09-01       Impact factor: 7.376

8.  Association between epilepsy and psychiatric disorders in adults with intellectual disabilities: systematic review and meta-analysis.

Authors:  Basma Akrout Brizard; Bharati Limbu; Carolina Baeza-Velasco; Shoumitro Deb
Journal:  BJPsych Open       Date:  2021-05-03

Review 9.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

Review 10.  Oxidative Stress in Down and Williams-Beuren Syndromes: An Overview.

Authors:  Marta Ferrari; Stefano Stagi
Journal:  Molecules       Date:  2021-05-24       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.